PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research reveals why diabetes patients are at risk for microvascular complications

A metabolic molecule is found to inhibit blood vessel growth in patients with diabetes, leading to impaired wound healing

2014-02-04
(Press-News.org) Contact information: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Research reveals why diabetes patients are at risk for microvascular complications A metabolic molecule is found to inhibit blood vessel growth in patients with diabetes, leading to impaired wound healing BOSTON -- Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

Now investigators from Beth Israel Deaconess Medical Center (BIDMC) have discovered that a molecule called PGC-1alpha -- which has previously been shown to spur the growth of blood vessels in muscle -- has the opposite effect in the endothelial cells of patients with diabetes, impairing blood vessel growth and leading to dangerous vascular complications.

Reported on-line today in the journal Cell Metabolism, the new findings not only help explain the molecular mechanisms underlying microvascular disease in diabetes patients, they also suggest that because PGC-1alpha has opposing effects in different cell types, its role as a potential new therapeutic target should be pursued with caution.

"Diabetes is the number one cause of amputations in the U.S.," explains senior author Zoltan Arany, MD, PhD, an investigator in BIDMC's CardioVascular Institute and Associate Professor of Medicine at Harvard Medical School (HMS). "While it's been believed that high levels of glucose were somehow to blame for the inability of chronic ulcers and infections to properly heal in these patients, it wasn't completely understood how this was happening."

With this new research, says Arany, it is apparent that high levels of blood glucose -- the hallmark of diabetes -- induces high levels of the PGC-1 alpha molecule in the endothelial cells lining the blood vessels. This, in turn, prevents endothelial cells from properly functioning, inhibiting blood vessel growth.

Arany's laboratory has studied PGC-1 alpha for more than a decade. Among the molecule's diverse roles, he has discovered that when body parts are jeopardized by poor circulation, PGC-1 alpha senses dangerously low levels of oxygen and nutrients in muscle cells and, in response, spurs the growth of new blood vessels, a process known as angiogenesis.

"In muscle cells, we've found that PGC-1alpha is pro-metabolic, and a critical regulator of angiogenesis," he explains. "But the key cells responsible for carrying out angiogenesis are the endothelial cells that line the blood vessels. We, therefore, decided to investigate the role of endothelial PGC-1 alpha in diabetes."

Through a series of cell culture experiments, as well as experiments in endothelial-specific genetic mouse models, the authors showed that PGC-1alpha in endothelial cells is induced by diabetes, which strongly inhibits endothelial migration and angiogenesis, and leads to vascular dysfunction.

"These findings were definitely surprising, because the effects of PGC-1 alpha in endothelial cells are the opposite of its effects in muscle cells," notes Arany. "In muscle cells, it's pro-metabolic and will call forth more blood vessels and come to the rescue when an injury or artery blockage leaves normal tissue starved for blood." But, he adds, it's now clear that this molecule behaves quite differently in endothelial cells, preventing blood vessel growth in diabetes patients and preventing wounds from healing.

"This isn't just interesting and paradoxical, it's a potentially very important finding that reminds us that the same molecule can do different things in different cell types," adds Arany, explaining that if you make a medication that targets a particular pathway, it could potentially have positive effects in one tissue or cell type, but negative effects in another.

"PGC-1 alpha is generally considered a 'good' molecule in terms of improving health when it's activated," he adds. "But as these findings show, this isn't the case in the vasculature – activation leads to potentially serious problems. This striking observation stresses the need for caution, for example, when designing drugs aimed at PGC-1 alpha."

INFORMATION:

Study co-authors include co-first authors Naoki Sawada (currently at the University of Chicago) and Aihua Jiang of BIDMC; Fumihiko Takizawa and Yoshihiro Ogawa of Tokyo Medical and Dental University, Adeel Safdar and Laura Benjamin of BIDMC; Andre Manika, Yevgenia Tesmenitsky, Hermann Kalwa, Juliano L. Sartoretto, Thomas Michel and Kevin Croce of Brigham and Women's Hospital; Kyu-Tae Kang of Duksung Women's University; Joyce Bischoff of Boston Children's Hospital; Hirotaka Watada of Juntendo University Graduate School of Medicine; Yasutomi Higashikuni of The University of Tokyo Graduate School of Medicine; Chase W. Kessinger and Farouc A. Jaffer of Massachusetts General Hospital; Masataka Sata of The University of Tokushima Graduate School; and Rica Tanaka of Jutendo University Graduate School of Medicine.

This study was supported by grants from the National Heart Lung Blood Institute, the National Institute of General Medicine Sciences, the American Heart Association, the American Diabetes Association, and the Ellison Medical Foundation, as well as the Takeda Science Foundation; Japan Vascular Disease Foundation; Astra Zeneca Research Grant and Suzuken Memorial Foundation.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.

The BIDMC health care team includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Health Care, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Evidence that shivering and exercise may convert white fat to brown

2014-02-04
A new study suggests that shivering and bouts of moderate exercise are equally capable of stimulating the conversion of energy-storing 'white fat' into energy-burning 'brown ...

Pain sensitivity may be influenced by lifestyle and environment, twin study suggests

2014-02-04
Researchers at King's College London have discovered that sensitivity to pain could be altered by a person's lifestyle and environment throughout their lifetime. The study is ...

Existing medicines show promise for treating stomach and bowel cancer

2014-02-04
PUBLIC RELEASE DATE: 4-Feb-2014 [ | E-mail ] var addthis_pub="eurekalert"; var addthis_options = "favorites, delicious, digg, facebook, twitter, google, newsvine, reddit, slashdot, stumbleupon, buzz, more" Share Contact: Vanessa Solomon solomon@wehi.edu.au 61-393-452-971 Walter and Eliza Hall Institute Rachel Steinhardt rsteinhardt@licr.org 212-450-1582 Ludwig Institute for Cancer Research Existing medicines show promise for treating stomach and bowel cancer Stomach and bowel cancer, two of the most common cancers worldwide, could be treated ...

Tricks of the trade: Study suggests how freelancers can land more jobs

2014-02-04
UNIVERSITY OF CALIFORNIA, BERKELEY'S HAAS SCHOOL OF BUSINESS – According to Elance.com, the online workplace lists more than three million registered freelancers ...

Stopping liver failure from painkiller overdose

2014-02-04
University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen). Published ...

A healthy balance

2014-02-04
STAT1 (signal transducer and activator of transcription 1) is a member of a family of transcription factors, cellular proteins that control whether and when ...

Happy people, safer sex

2014-02-04
Having a good week? It may lead to healthier choices. If you are a man with HIV, you may be more likely ...

When it comes to memory, quality matters more than quantity

2014-02-04
The capacity of our working memory is better explained by the quality of memories we can store than by their number, a team of psychology researchers has concluded. Their analysis, which appears in the latest ...

Despite burden, Sjögren's syndrome may not impede function

2014-02-04
BOSTON (February 4, 2014) —People living with Sjögren's syndrome, ...

Speech disrupts facial attention in 6-month-olds who later develop autism

2014-02-04
Philadelphia, PA, February 4, 2014 – From birth, infants naturally show a preference for human contact and interaction, including faces and voices. These ...

LAST 30 PRESS RELEASES:

Einstein Probe releases its Science White Paper

Music-based therapy may improve depressive symptoms in people with dementia

No evidence that substituting NHS doctors with physician associates is necessarily safe

At-home brain speed tests bridge cognitive data gaps

CRF appoints Josep Rodés-Cabau, M.D., Ph.D., as editor-in-chief of structural heart: the journal of the heart team

Violent crime is indeed a root cause of migration, according to new study

Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment

Impact of COVID-19 on education not going away, UM study finds

School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods

Three Speculum articles recognized with prizes

ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology

Incarcerated people are disproportionately impacted by climate change, CU doctors say

ESA 2025 Graduate Student Policy Award Cohort Named

Insomnia, lack of sleep linked to high blood pressure in teens

Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults

Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk

Large study of dietary habits suggests more plant oils, less butter could lead to better health

Butter and plant-based oils intake and mortality

20% of butterflies in the U.S. have disappeared since 2000

Bacterial ‘jumping genes’ can target and control chromosome ends

Scientists identify genes that make humans and Labradors more likely to become obese

Early-life gut microbes may protect against diabetes, research in mice suggests

Study raises the possibility of a country without butterflies

Study reveals obesity gene in dogs that is relevant to human obesity studies

A rapid decline in US butterfly populations

Indigenous farming practices have shaped manioc’s genetic diversity for millennia

Controlling electrons in molecules at ultrafast timescales

Tropical forests in the Americas are struggling to keep pace with climate change

Brain mapping unlocks key Alzheimer’s insights

Clinical trial tests novel stem-cell treatment for Parkinson’s disease

[Press-News.org] Research reveals why diabetes patients are at risk for microvascular complications
A metabolic molecule is found to inhibit blood vessel growth in patients with diabetes, leading to impaired wound healing